green weeds under water

A world of possibilities harnessed

Translating Complex Natural Materials into Compliant, Commercially Viable Products

Overview below or access technical case study deep dives here

Regulatory Evaluation and Ongoing Dossier Stewardship Under REACH

Overview

Following submission of a REACH registration dossier through IUCLID and REACH-IT, registrants may become subject to multiple stages of regulatory review and ongoing compliance obligations under ECHA processes.

Registration does not represent the end of the regulatory pathway. Dossiers may undergo:

  • Technical Completeness Checks (TCC),
  • manual dossier review,
  • compliance checks,
  • substance evaluation,
  • or broader regulatory scrutiny under evolving REACH requirements.

For complex bio-based substances and UVCBs, regulatory evaluation presents additional complexity due to:

  • variable composition,
  • evolving datasets,
  • analytical interpretation considerations,
  • and the need to maintain alignment between substance identity, data and use over time.

This creates a requirement for ongoing dossier stewardship, scientific oversight and stakeholder coordination throughout the lifecycle of the registration.


Core Challenge

The primary challenge following dossier submission was maintaining long-term regulatory robustness across evolving technical and compliance requirements.

Key considerations included:

  • successful completion of ECHA Technical Completeness Checks
  • preparation for potential manual dossier review
  • consistency across interconnected dossier sections
  • ongoing maintenance of IUCLID datasets
  • evaluation of potential substance selection under CoRAP
  • management of additional information requests or study requirements
  • alignment of new data with existing classification and substance identity
  • coordination between registrants, laboratories and regulatory stakeholders

For complex substances, even relatively small changes in:

  • analytical interpretation,
  • compositional understanding,
  • or hazard information

may create implications across multiple regulatory obligations.


Regulatory Evaluation and Stewardship Approach

Technical Completeness Check (TCC)

Following submission, dossiers were reviewed against ECHA Technical Completeness Check requirements to verify:

  • presence of mandatory administrative information
  • completion of required IUCLID fields
  • endpoint coverage against applicable REACH Annex requirements
  • inclusion of study summaries and supporting documentation
  • and consistency of core dossier elements

Successful completion of TCC is required before registration can proceed further within the REACH process.


Manual Dossier Review and Compliance Readiness

In addition to automated completeness checks, dossier structures and supporting data were prepared to support potential manual regulatory review.

This included:

  • consistency checks across substance identity and endpoint data
  • review of classification alignment
  • evaluation of study applicability
  • and verification of justifications supporting data interpretation or adaptation approaches

For UVCB substances, regulatory scrutiny may extend to:

  • substance sameness,
  • compositional boundaries,
  • analytical interpretation,
  • and data applicability across variable constituent profiles.

CoRAP and Substance Evaluation Considerations

Potential implications of Community Rolling Action Plan (CoRAP) selection were evaluated as part of long-term stewardship planning.

Substance evaluation under CoRAP may result in:

  • requests for additional information
  • further toxicological or ecotoxicological studies
  • clarification of substance identity
  • refinement of exposure information
  • or reassessment of hazard interpretation

Preparation activities considered how evolving regulatory priorities may affect ongoing dossier obligations over time.


Ongoing Dossier Maintenance and Updates

REACH registration requires continued maintenance of dossier information following submission.

Ongoing stewardship activities included:

  • review of new analytical or hazard data
  • assessment of compositional changes
  • update of classification information where required
  • incorporation of additional study data
  • and maintenance of IUCLID dossier consistency

This was particularly important where:

  • manufacturing processes evolved,
  • source materials changed,
  • or new scientific understanding emerged.

Study Commissioning and Data Management

Where additional information requirements arose, further studies were evaluated, commissioned and managed in line with regulatory expectations.

This included:

  • coordination with laboratories and testing facilities
  • monitoring of study progression
  • review of generated datasets
  • and integration of results into existing dossier frameworks

Particular attention was required to ensure consistency between:

  • newly generated data,
  • existing endpoint information,
  • and established substance identity definitions.

Stakeholder Engagement and Joint Submission Coordination

Ongoing regulatory management frequently required coordination across:

  • lead registrants
  • co-registrants
  • laboratories
  • downstream stakeholders
  • and regulatory representatives

This supported alignment of:

  • dossier updates
  • data sharing activities
  • classification interpretation
  • and broader compliance strategy considerations.

Outcome

  • Technical Completeness Check requirements successfully addressed
  • Dossiers prepared for potential manual review and compliance evaluation
  • Long-term dossier stewardship programmes established
  • CoRAP and substance evaluation considerations assessed
  • Ongoing study management and data integration supported
  • IUCLID datasets maintained in alignment with evolving regulatory obligations
  • Stakeholder coordination maintained across registration and compliance activities
  • Long-term regulatory readiness supported throughout the dossier lifecycle

Key Consideration

Under REACH, registration represents the beginning of an ongoing regulatory lifecycle rather than a single submission event. For complex bio-based substances, maintaining regulatory robustness requires continuous alignment across substance identity, analytical understanding, hazard data, classification and stakeholder coordination as scientific and regulatory expectations evolve over time.